Pfizer (PFE) Stock: Company Files Dual Lawsuits Against Novo Nordisk Over Metsera Deal

TLDR Pfizer filed two lawsuits against Novo Nordisk over competing $9 billion Metsera bid Novo’s 30-month closing period compared to Pfizer’s nine-month timeline sparks antitrust concerns Metsera board favors Novo’s offer after shareholder-driven board overhaul Delaware judge hears case Tuesday as Pfizer faces deadline to submit higher bid Pfizer sees Metsera as key entry into [...]

The post Pfizer (PFE) Stock: Company Files Dual Lawsuits Against Novo Nordisk Over Metsera Deal appeared first on Blockonomi.